0346 GMT - Frencken Group's 2H revenue is likely to be broadly stable compared with 1H, UOB Kay Hian analyst John Cheong writes in a note. The technology solutions provider's 1H revenue rose 16% on year, with the semiconductor and medical segments reporting growth. The company expects these segments' 2H revenue to remain stable. However, the semiconductor segment could be weighed by factors including the ambiguity of U.S. tariffs on chips and the impact on the semiconductor-equipment sector, Cheong says. UOB KH maintains a buy rating on the stock with a target price of S$2.08. Shares are at S$1.42. (amanda.lee@wsj.com)
(END) Dow Jones Newswires
August 19, 2025 23:46 ET (03:46 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.